Publicis Groupe’s Starcom and Epsilon have been awarded the global media assignment for Novartis. The assignment, which covers media planning, buying, data and analytics, includes 60 markets globally and is effective January 1, 2020.
As one of the world’s leading global medicines company, Novartis is aggressively reimagining medicine to improve and extend people’s lives. Leveraging science-based innovation to deliver better patient outcomes, Novartis products reach more than 750 million people globally.
To deliver data-driven marketing strategy and accelerate business transformation, Starcom and Epsilon created a bespoke solution: NovartisONE2. This integrated, co-located solution combines the power of Starcom and Epsilon with Publicis Groupe’s unmatched expertise in healthcare marketing and media.
“Just as Novartis seeks to reimagine medicine, we too seek to reimagine and transform how we deliver data-driven marketing strategies for our clients,” said John Sheehy, Global Brand President, Starcom Worldwide. “Rooted in a data-led, digital-first approach, NovartisONE2 unites Starcom and Epsilon to deliver capability that is agile, collaborative and relentlessly focused driving business outcomes, along with delivering personalised experiences at scale for Novartis’ complex and evolving consumers.”
The selection of NovartisONE2 extends and deepens Publicis’ relationship with Novartis, with Starcom, the pitch incumbent, having served as its media agency since 2010.
Source: Publicis Groupe